Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice

Yijie Zhang,Mingwei Bao,Mingyan Dai,Xin Wang,Wenbo He,Tuantuan Tan,Dandan Lin,Wei Wang,Ying Wen,Rui Zhang

DOI: https://doi.org/10.1186/s12933-015-0234-z

IF: 8.949

2015-06-03

Cardiovascular Diabetology

Abstract:BackgroundFatty acid (FA) catabolism abnormality has been proved to play an important role in obesity-related cardiomyopathy. We hypothesized that cardiospecific suppression of CD36, the predominant membrane FA transporter, would protect against obesity-related cardiomyopathy.MethodsFour-wk-old male C57BL/6 J mice were fed with either high-fat-diet (HFD) or control-normal-diet for 2 wk. Then they were subjected to intramyocardial injection with recombinant lentiviral vectors containing short hairpin RNAs to selectively downregulate the expression of either cardiac CD36 or irrelevant gene by RNA interference. After a 10-wk continuation of the diet, biochemical, functional, morphological, histological, metabolic and molecular profiles were assessed.ResultsHFD administration elicited obesity, cardiac hypertrophy and systolic dysfunction accompanied with elevated serum levels of blood urea nitrogen (BUN), creatinine, fasting serum glucose (FSG), total cholesterol (TC) and triglyceride. Additionally, HFD consumption promoted lipid accumulation and reactive oxygen species (ROS) generation in the cardiomyocytes. Cardiospecific CD36 inhibition protected against HFD induced cardiac remodeling by decreasing heart/body weight ratio, increasing left ventricular (LV) ejection fraction and fractional shortening as well as normalizing LV diameter, without influencing body weight gain. Inhibition of cardiac CD36 also mitigated obesity induced alteration in BUN, creatinine and triglyceride, but had no effect on FSG or TC. Moreover, cardiospecific CD36 deficiency corrected myocardial lipid overaccumulation and intracellular ROS overproduction that were induced by HFD feeding.ConclusionsCardiospecific CD36 inhibition protects against the aggravation of cardiac functional and morphological changes associated with HFD induced obesity. CD36 represents a potential therapeutic target for obesity cardiomyopathy.

cardiac & cardiovascular systems,endocrinology & metabolism

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the pathological mechanism of obesity - related cardiomyopathy and its potential treatment targets. Specifically, the researchers hypothesized that by specifically inhibiting CD36 (a major membrane fatty acid transporter) in the heart, the heart could be protected from obesity - related cardiomyopathy caused by a high - fat diet (HFD). CD36 plays a key role in fatty acid uptake, and its over - expression may lead to excessive myocardial lipid accumulation, triggering oxidative stress and myocardial dysfunction. Therefore, the main goal of the study was to verify whether cardiac - specific CD36 inhibition could prevent cardiac hypertrophy and systolic dysfunction in obese mice induced by a high - fat diet. The research methods included using recombinant lentiviral vectors carrying short - hairpin RNA (shRNA) to selectively down - regulate the expression of cardiac CD36, and then evaluating the biochemical, functional, morphological, histological, metabolic and molecular characteristics of mice after continuing a high - fat diet for 10 weeks. The research results showed that cardiac - specific CD36 inhibition could indeed reduce the heart/body weight ratio, increase the left ventricular ejection fraction and fractional shortening, and restore the normal left ventricular diameter without affecting body weight gain. In addition, inhibition of cardiac CD36 could also alleviate the changes in blood urea nitrogen (BUN), creatinine and triglyceride levels related to obesity, but had no effect on fasting blood glucose (FSG) or total cholesterol (TC). Further analysis showed that cardiac - specific CD36 deficiency could correct myocardial lipid overaccumulation and excessive intracellular ROS production caused by a high - fat diet. In conclusion, this study demonstrated that cardiac - specific CD36 inhibition can effectively counteract the cardiac function and morphological changes related to high - fat - diet - induced obesity, suggesting that CD36 may become a potential treatment target for obese cardiomyopathy.

Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice

CD36 as a target to prevent cardiac lipotoxicity and insulin resistance

Cardiomyocyte‐Specific Ablation of the Long‐Chain Fatty Acid Transporter CD36 Accelerates the Progression of Pressure Overload‐Induced Heart Failure in Mice

Abstract 13865: Cardiac Specific Deletion of Endothelin-1 Receptor a Rescues the Heart from High-Fat Diet-Induced Cardiac Dysfunction Via Regulating Autophagy

Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling

CARD9 Knockout Ameliorates Myocardial Dysfunction Associated with High Fat Diet-Induced Obesity.

Folic Acid Delays Development of Atherosclerosis in Low‐density Lipoprotein Receptor‐deficient Mice

LuHui Derivative, A Novel Compound That Inhibits the Fat Mass and Obesity-Associated (FTO), Alleviates the Inflammatory Response and Injury in Hyperlipidemia-Induced Cardiomyopathy

Intermittent Fasting Improves High-Fat Diet-Induced Obesity Cardiomyopathy via Alleviating Lipid Deposition and Apoptosis and Decreasing m6A Methylation in the Heart

Cardiomyocyte-specific knockout of endothelin receptor a attenuates obesity cardiomyopathy.

Abstract 15583: Toll-Like Receptor 4 Knockout Preserves Cardiac Function in High Fat Diet-Induced Obesity

Abstract 10237: Targeting on Nrf2/Sesn2 Signaling to Rescue Cardiac Dysfunction During High Fat Diet-Induced Obesity

Cluster Differentiating 36 (CD36) Deficiency Attenuates Obesity-Associated Oxidative Stress in the Heart

Lipid overload-induced RTN3 activation leads to cardiac dysfunction by promoting lipid droplet biogenesis

A20 prevents obesity-induced development of cardiac dysfunction

Enhancing Fatty Acids Oxidation via L-Carnitine Attenuates Obesity-Related Atrial Fibrillation and Structural Remodeling by Activating AMPK Signaling and Alleviating Cardiac Lipotoxicity

Transcriptomic insights into the lipotoxicity of high-fat high-fructose diet in rat and mouse

Modulation of cardiac resident macrophages immunometabolism upon high-fat-diet feeding in mice

LncRNA ZNF593-AS Alleviates Diabetic Cardiomyopathy via Suppressing IRF3 Signaling Pathway

Lipidomics Reveals Myocardial Lipid Composition in a Murine Model of Insulin Resistance Induced by a High-Fat Diet

Adipocyte-specific deletion of HuR induces spontaneous cardiac hypertrophy and fibrosis